Showing Results for
From:PLoS ONE (Vol. 16, Issue 3) Peer-ReviewedTechnological advances in molecular profiling have enabled the comprehensive identification of common regions of gene amplification on chromosomes (amplicons) in muscle invasive bladder cancer (MIBC). One such region is...
From:PLoS ONE (Vol. 11, Issue 10) Peer-ReviewedBackground-Aim Early breast cancer is a heterogeneous disease, and, therefore, prognostic tools have been developed to evaluate the risk for distant recurrence. In the present study, we sought to develop a risk for...
From:PLoS ONE (Vol. 10, Issue 5) Peer-ReviewedBackground Although host immune response is an emerging prognostic factor for colorectal cancer, there is no consensus on the optimal methodology, surrogate markers or tissue for study. Patients and Methods...
From:PLoS ONE (Vol. 8, Issue 8) Peer-ReviewedPurpose Local recurrence is the major manifestation of treatment failure in patients with operable laryngeal carcinoma. Established clinicopathological factors cannot sufficiently predict patients that are likely to...
Choose how you want to be alerted when new results for your search become available.
Subscribe to Gale's RSS feed to get content delivered to your favorite RSS aggregator. Copy and paste the URL below into your reader:
Tell us where to send the alert and how often you want to receive it